Recent news on Vitravene

Antisense—down, but not out  -  Apr 30, 2007
Nature.com (subscription),After 20 years of technology improvements, only one antisense drug is on the market: Vitravene (fomivirsen), developed by Isis Pharmaceuticals (Carlsbad,

eXegenics Inc.: New Company; New Technology  -  Apr 18, 2007
Seeking Alpha,...which have been successful so far; Macugen mentioned above, an aptamer, and Vitravene from ISIS, an antisense oligonucleotide against CMV retinitis.

Antisense drugs stop making sense?  -  26 Dec 2006
OutSourcing-Pharma.com,This was Isis Pharmaceuticals' Vitravene (fomivirsen), a treatment for cytomegalovirus retinitis (CMV) in immunocompromised patients, such as those with

Isis Shares Jump on Positive Initiation  09 Nov 2006
The company already has one antisense drug on the market, called Vitravene, to fight a virus and an eye infection called retinitis in AIDS patients. ... -Houston Chronicle, In Brief  Nov 1, 2006
Since the 1998 FDA approval of Isis Pharmaceuticals' Vitravene (fomivirsen) for treating certain viral eye infections in AIDS patients, no other antisense drug ... -Nature.com (subscription),

Research and Markets: Acuity Pharmaceuticals and Sirna ...  Apr 5, 2006
Companies have been testing ASOs in the clinic for ten years, and one antisense product, fomivirsen (Isis Pharmaceuticals' Vitravene), is on the market. ... - Business Wire



Significant Technological Challenges Remain for the Development of ...  Feb 2, 2006
Companies have been testing ASOs in the clinic for ten years, and one antisense product, fomivirsen (Isis Pharmaceuticals' Vitravene), is on the market. ... - Genetic Engineering News

Germ Sensors  Jan 26, 2006
Over the past 12 months Isis--which has just one commercial drug, Vitravene, a treatment for retinal virus infections that is marketed by Novartis--lost $122 ... - Forbes

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional